login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AYTU BIOPHARMA INC (AYTU) Stock News
USA
- NASDAQ:AYTU -
US0547548588
-
Common Stock
2.18
USD
+0.01 (+0.46%)
Last: 10/29/2025, 8:14:16 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AYTU Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: ACCESS Newswire
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
17 days ago - By: Zacks Investment Research
- Mentions:
ALK
CNM
New Strong Sell Stocks for Oct. 13th
20 days ago - By: ACCESS Newswire
Aytu BioPharma to Present at Upcoming October 2025 Conferences
a month ago - By: ACCESS Newswire
- Mentions:
LCUT
NTRB
GEVO
XHLD
...
11 Company Presentations Today at The MicroCap Rodeo Conference
a month ago - By: ACCESS Newswire
Aytu BioPharma to Present at Upcoming September 2025 Conferences
a month ago - By: ACCESS Newswire
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
a month ago - By: Benzinga
- Mentions:
AIR
AZO
MU
WOR
...
Earnings Scheduled For September 23, 2025
a month ago - By: Benzinga
Earnings Outlook For Aytu BioPharma
4 months ago - By: ACCESS Newswire
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
5 months ago - By: ACCESS Newswire
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock
a month ago - By: Stocktwits
- Mentions:
SPY
QQQ
DJI
SPX
...
Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch
a month ago - By: ACCESS Newswire
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
2 months ago - By: Zacks Investment Research
- Mentions:
A
Agilent Technologies (A) Surpasses Q3 Earnings and Revenue Estimates
3 months ago - By: Yahoo Finance
- Mentions:
NVDA
Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition
4 months ago - By: Yahoo Finance
Aytu Boosts Liquidity with Eclipse Loan Extension
4 months ago - By: ACCESS Newswire
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
5 months ago - By: ACCESS Newswire
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan
5 months ago - By: Yahoo Finance
Aytu BioPharma to commercialise Exxua for MDD in the US
5 months ago - By: ACCESS Newswire
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States
Please enable JavaScript to continue using this application.